Skip to main content
. 2014 Sep 19;4(4):302–311. doi: 10.1016/j.jceh.2014.08.007

Figure 3.

Figure 3

Dose schedules of terlipressin and albumin derived from the two main controlled clinical trials devoted to the treatment of patients with cirrhosis and hepatorenal syndrome (i.v.: intravenous; CVP: central venous pressure; sCr: serum creatinine; HRS: hepatorenal syndrome).